Hand Eczema Relief Just Got Better: Ceradan® Advanced Hand Balm Launched By Hyphens Pharma

Hyphens Pharma International Limited, a top player in Singapore’s pharmaceutical and consumer healthcare sector, proudly introduces the Ceradan® Advanced Hand Balm. This new product joins the Ceradan line, tailored for managing atopic dermatitis, commonly referred to as eczema. In collaboration with the Agency for Science, Technology, and Research (A*STAR), the Ceradan Advanced Hand Balm is the first hand balm to feature patented active pH control technology, specifically crafted for individuals with hand eczema.

Hand eczema, marked by an increase in skin pH and a weakened barrier, makes hands vulnerable to irritants, leading to inflammation. Healthcare workers are especially prone, with 38% affected, compared to only 9% of the general public, primarily due to frequent handwashing. Ceradan® Advanced Hand Balm tackles these eczema challenges by offering long-term pH balance with its patented active pH control technology. This breakthrough helps manage the condition by maintaining skin barrier stability, boosting antimicrobial protection, and reducing inflammation and itching.

Clinical trials have demonstrated a notable increase in skin ceramide levels following the use of Ceradan® Advanced Hand Balm¹. Its unique 3:1:1 ceramide-dominant formula, enriched with essential skin lipids, aids in restoring the skin’s barrier. This restoration is crucial for those suffering from hand eczema, as their symptoms can vary from dryness and itching to more severe conditions like blisters, vesicles, cracks, and even bleeding. By reinforcing the skin barrier, the balm provides much-needed relief from these discomforts.

A'STAR played a key role in the creation of the Advanced Hand Balm, overseeing its formulation and conducting stability tests to guarantee it met the necessary quality benchmarks for wider use. Afterward, they facilitated the production scale-up and provided the technology transfer along with the manufacturing protocol to enable commercial production. A'STAR's scientists also tested the balm's efficacy, focusing on its benefits for skin health by tracking hydration levels and essential markers such as ceramide content.

"The launch of the Ceradan Advanced Hand Balm marks a significant milestone in our mission to provide effective, science-backed solutions for skin health. Recognizing the unique needs of healthcare professionals, it offers targeted relief and lasting protection for hand eczema, empowering them to gain control over their symptoms and regain a better quality of life,” mentioned Lim See Wah, Executive Chairman and CEO of Hyphens Pharma.

Mr Lim Li-Wei, Executive Director of Innovation & Enterprise, A'STAR, said in a statement, "Our research partnership with Hyphens Pharma showcases A'STAR's commitment to supporting enterprise growth in Singapore's innovation-driven economy. Through. translational research collaborations and intellectual property licensing, we work closely with industry partners to turn scientific advancements into innovative products, solutions and services, driving economic impact for Singapore."